骨形成蛋白6(BMP6)重組蛋白
Recombinant Bone Morphogenetic Protein 6 (BMP6)
VGR; VGR1; Vegetal Related Growth Factor(TGFB-Related); VG-1-related protein
- 編號RPA646Mu01
 - 物種Mus musculus (Mouse,小鼠)相同的名稱,不同的物種。
 - 來源原核表達(dá)
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細(xì)胞定位分泌
 - 預(yù)測分子量15.6kDa
 - 實(shí)際分子量16kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Gln379~Ala506 with N-terminal His Tag
 - 緩沖液成份20mM Tris, 150mM NaCl緩沖液(pH8.0, 含有1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose和Proclin300)
 - 性狀凍干粉
 - 純度> 95%
 - 等電點(diǎn)8.2
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價(jià)格¥ 1200¥ 3000¥ 6000¥ 18000¥ 45000
 - 欲了解實(shí)際交易價(jià)格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個(gè)月,-80°C不超過12個(gè)月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Mus musculus (Mouse,小鼠) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPA646Mu02 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA646Mu01 | 骨形成蛋白6(BMP6)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA646Mu01 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA646Mu02 | 骨形成蛋白6(BMP6)多克隆抗體 | WB; IHC; ICC; IP. | 
| SEA646Mu | 骨形成蛋白6(BMP6)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA646Mu | 骨形成蛋白6(BMP6)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| International Journal of Cardiology | Valvular osteoclasts in calcification and aortic valve stenosis severity[PubMed: 23452891] | 
| Polskie Archiwum Medycyny Wewn Trznej | New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis[PubMed: 23111696] | 
| PLoS ONE | A Combinatorial Relative Mass Value Evaluation of Endogenous Bioactive Proteins in Three-Dimensional Cultured Nucleus Pulposus Cells of Herniated Intervertebral Discs: Identification of Potential Target Proteins for Gene Therapeutic Approaches[Plosone: Source] | 
| journal of biomedical materials research part b-applied biomaterials | In vitro chondrogenesis by BMP6 gene therapy[Pubmed: 23077084] | 
| Journal of Clinical Pathology | Association of hepatic oxidative stress and iron dysregulation with HCC development after interferon therapy in chronic hepatitis C[PubMed: 26290259] | 
| Clinical?and Experimental Pharmacology and Physiology | Bone morphogenetic protein 6—a possible new player in pathophysiology of heart failure[pubmed:27592865] | 
| International Journal of Biological Macromolecules | SEQUENTIAL IGF-1 AND BMP-6 RELEASING CHITOSAN/ALGINATE/PLGA HYBRID SCAFFOLDS FOR PERIODONTAL REGENERATION[pubmed:28601648] | 
| Elife | The transcriptomic and epigenetic map of vascular quiescence in the continuous lung endothelium[Pubmed:29749927] | 




